| GENOTROPIN MINIQUICK 2.0 mg powder and solvent for solution for injection PA0822/128/012 |
Somatropin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Glyceryl Trinitrate 5 mg/ml Sterile Concentrate PA0822/204/001 |
Glyceryl trinitrate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Halcion 125 micrograms Tablets PA0822/129/002 |
Triazolam |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Halcion 250 microgram Tablets PA0822/129/001 |
Triazolam |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Hympavzi 150 mg solution for injection in pre-filled pen EU/1/24/1874/002 |
Marstacimab |
Pfizer Europe MA EEIG |
— |
| Hympavzi 150 mg solution for injection in pre-filled syringe EU/1/24/1874/001 |
Marstacimab |
Pfizer Europe MA EEIG |
— |
| Hypovase 0.5mg Tablets PA0822/195/001 |
Prazosin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| IBRANCE 100 mg film-coated tablets EU/1/16/1147/0012-013 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 100 mg hard capsules EU/1/16/1147/003-004 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 125 mg film-coated tablets EU/1/16/1147/014-015 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 125 mg hard capsules EU/1/16/1147/005-006 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 75 mg film-coated tablets EU/1/16/1147/010-011 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| IBRANCE 75 mg hard capsules EU/1/16/1147/001-002 |
Palbociclib |
Pfizer Europe MA EEIG |
— |
| Inflectra 100 mg powder for concentrate for solution for infusion EU/1/13/854/001-005 |
Ct-p13 (infliximab) |
Pfizer Europe MA EEIG |
— |
| Inlyta 3 mg film-coated tablets EU/1/12/777/007-009 |
Axitinib |
Pfizer Europe MA EEIG |
— |
| Inlyta 5 mg film-coated tablets EU/1/12/777/004-006 |
Axitinib |
Pfizer Europe MA EEIG |
— |
| Inlyta 7 mg film-coated tablets EU/1/12/777/010-012 |
Axitinib |
Pfizer Europe MA EEIG |
— |
| Inlyta1 mg film-coated tablets EU/1/12/777/001-003 |
Axitinib |
Pfizer Europe MA EEIG |
— |
| Ketalar 10mg/ml Solution for Injection/Infusion PA0822/013/001 |
Ketamine hydrochloride |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Ketalar 50 mg/ml Solution for Injection/Infusion PA0822/013/002 |
Ketamine hydrochloride |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Levetiracetam Hospira 100 mg/ml concentrate for solution for infusion EU/1/13/889/001-002 |
Levetiracetam |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/001 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/002-004 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/005-007 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/008-010 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/011-013 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Litfulo 50 mg hard capsules EU/1/23/1755/001-003 |
Ritlecitinib |
Pfizer Europe MA EEIG |
— |
| Loniten 5 mg tablets PA0822/130/001 |
Minoxidil |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Lopid 300 mg capsules, hard PA0822/014/001 |
Gemfibrozil |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Lopid 600 mg film-coated tablets PA0822/014/002 |
Gemfibrozil |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Lorviqua 100 mg film-coated tablet EU/1/19/1355/002 |
LORLATINIB |
Pfizer Europe MA EEIG |
— |
| Lorviqua 25 mg film-coated tablets EU/1/19/1355/001 |
LORLATINIB |
Pfizer Europe MA EEIG |
— |
| Meronem I.V. 1g powder for solution for injection or infusion PA0822/190/002 |
Meropenem Anhydrous |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate 1 g/10 ml Injection PA0822/206/006 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate 5 g/50 ml Injection PA0822/206/007 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate 5 mg/2 ml Injection PA0822/206/001 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Methotrexate Pfizer 50mg/2ml Injection PA0822/206/002 |
Methotrexate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| MINESSE 60 micrograms/15 micrograms film-coated tablet PA0822/144/001 |
Gestodene, Ethinylestradiol |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| Minulet 75 micrograms/30 micrograms coated tablets PA0822/093/001 |
Ethinyloestradiol, Gestodene |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Mycobutin 150mg Hard Capsules PA0822/109/001 |
Rifabutin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| MYLOTARG 5 mg powder for concentrate for solution for infusion EU/1/18/1277/001 |
Gemtuzumab ozogamicin |
Pfizer Europe MA EEIG |
— |
| NeisVac-C 0.5 ml Suspension for injection in pre-filled syringe. Meningococcal Group C Polysaccharide Conjugate Vaccine Adsorbed PA0822/183/001 |
Neisseria meningitidis c, Tetanus toxoid |
Pfizer Healthcare Ireland Unlimited Company |
Not marketed |
| NGENLA 24 mg/ 1.2 ml Solution for injection EU/1/21/1617/001 |
Somatrogon |
Pfizer Europe MA EEIG |
— |
| NGENLA 60 mg/ 1.2 ml Solution for injection EU/1/21/1617/002 |
Somatrogon |
Pfizer Europe MA EEIG |
— |
| Nimenrix powder and solvent for solution for injection in pre-filled syringe EU/1/12/767/001-007 |
N.meningitidis serogroup a polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup c polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup w polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup y polysaccharide conjugated to tetanus toxoid |
Pfizer Europe MA EEIG |
— |
| NIPENT 10 mg powder for solution for injection, powder for solution for infusion PA0822/228/001 |
Pentostatin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Nivestim 12 MU/0.2 ml solution for injection/infusion EU/1/10/631/001-3 |
Filgrastim |
Pfizer Europe MA EEIG |
— |
| Nivestim 30 MU/0.2 ml solution for injection/infusion EU/1/10/631/004-6 |
Filgrastim |
Pfizer Europe MA EEIG |
— |
| Nivestim 48 MU/0.2 ml solution for injection/infusion EU/1/10/631/007-9 |
Filgrastim |
Pfizer Europe MA EEIG |
— |
| Noradrenaline (Norepinephrine) 1:1000 Concentrate For Solution For Infusion PA0822/219/001 |
Noradrenaline acid tartrate |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |